Turning Point Therapeutics, Inc.·4

Apr 12, 6:46 PM ET

Sun Brian 4

4 · Turning Point Therapeutics, Inc. · Filed Apr 12, 2022

Insider Transaction Report

Form 4
Period: 2022-04-11
Sun Brian
SVP & General Counsel
Transactions
  • Award

    Common Stock

    2022-04-11+45,00045,000 total
  • Award

    Stock Option (right to buy)

    2022-04-11+195,000195,000 total
    Exercise: $24.65Exp: 2032-04-10Common Stock (195,000 underlying)
Footnotes (2)
  • [F1]Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan.
  • [F2]25% of the shares vest on April 11, 2023 and 1/48th of the shares vest monthly thereafter over the next three years.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION